Nuvisan

Nuvisan company information, Employees & Contact Information

Explore related pages

Related company profiles:

Your partner of choice in bringing therapeutics to life, Nuvisan is the unique CRO/CDMO with extensive pharma experience and industry-leading scientific expertise, providing highest-quality end-to-end solutions. From enabling target understanding to helping get innovative medicines to the patients who need them, we provide support that streamlines and accelerates drug discovery and development.
Looking for a particular Nuvisan employee's phone or email?

Nuvisan Questions

News

Opening the Door to a New Treatment Paradigm: The Re-emergence of Chymase Inhibitors - ACS Publications

Opening the Door to a New Treatment Paradigm: The Re-emergence of Chymase Inhibitors ACS Publications

NUVISAN receives US$9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines - PR Newswire

NUVISAN receives US$9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines PR Newswire

Nuvisan and ALS Transaction - William Blair

Nuvisan and ALS Transaction William Blair

Bayer to transfer research unit in Berlin to Nuvisan - Pharmaceutical Technology

Bayer to transfer research unit in Berlin to Nuvisan Pharmaceutical Technology

Bayer, Nuvisan to create drug discovery research unit in Berlin - drugdiscoverytrends.com

Bayer, Nuvisan to create drug discovery research unit in Berlin drugdiscoverytrends.com

Bayer, looking to grow pharmaceutical sales, seeds new research center - BioPharma Dive

Bayer, looking to grow pharmaceutical sales, seeds new research center BioPharma Dive

Nuvisan Pharma Acquires Inamed GmbH - Contract Pharma

Nuvisan Pharma Acquires Inamed GmbH Contract Pharma

ALS shares drop on news of Nuvisan takeover - Capital Brief

ALS shares drop on news of Nuvisan takeover Capital Brief

ALS rethinks stake in pharma R&D business Nuvisan - AFR

ALS rethinks stake in pharma R&D business Nuvisan AFR

ALS writes down $258m drug stake, buys remainder for nothing - AFR

ALS writes down $258m drug stake, buys remainder for nothing AFR

ALS shares extend losses after acquisition spree - Capital Brief

ALS shares extend losses after acquisition spree Capital Brief

ALS execs to get more, despite ‘strike’ against report - The Australian

ALS execs to get more, despite ‘strike’ against report The Australian

Top Nuvisan Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant